NCT01122563View on ClinicalTrials.gov

A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to Treatment

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Overactive Bladder
Interventions
DRUG

Solifenacin

oral

Trial Locations (3)

Unknown

Bandung

Jakarta

Surabaya

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Indonesia Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY